Sweden

Emergency contraception (EC) is available in Sweden: LNG EC, UPA EC, and the use of IUD for EC are included in national policies for family planning, and local pharmacies, hospitals, and family planning clinics distribute EC. LNG EC and UPA EC are available free of charge from youth clinics, and copper IUDs may also be provided free of charge depending on the area.

Sexual & reproductive health background information

Female population aged 15-49 Mean age at first sexual intercourse Mean age at birth of first child Total fertility rate % use of modern contraceptive methods
Estimate 2,124,0001 16.12 28.93 1.94 64.8%5
Year 2010 2005 2010 2011 1996

Accessibility & prescription status

In Sweden LNG EC is available over the counter from pharmacies, hospitals, and family planning clinics, which means that EC can be purchased without a prescription, the drug is on the shelves, and a woman can just take it to the check-out counter. Since 2015 UPA EC can also  be purchased without a prescription from pharmacies, hospitals, and family planning clinics. The Yuzpe regimen is specifically not recommended for use in Sweden.

Physicians and also midwives are authorized to to provide or prescribe EC.

Cost

Type of EC Approximate Cost Brand(s) Available
LNG € 17 NorLevo 1.5mg, Postinor 1.5
UPA € 25 ellaOne

LNG EC and UPA EC are free when they are procured from youth clinics and some other types of clinics in Sweden. Copper IUDs are also free in most areas. Otherwise, though, the cost of EC is not reimbursed or covered by social security in Sweden.

Guidelines & common practices

Antikonception – Behandlingsrekommendation are Sweden’s guidelines dedicated exclusively to EC.  They were published in 2005 and are being updated. These guidelines include recommendations on LNG EC as well as on the use of IUD for EC. Recommendations on UPA EC are included in additional information that was distributed after the original guidelines were published in 2005.

Health care providers often provide general information about EC during regular consultations and sometimes prescribe EC in advance of need. Health care providers do not require a pregnancy test or a pelvic exam before prescribing EC.

EC use

Ever use of EC EC use in the last 12 months % with no prescription Repeated use of EC in last 12 months
Estimate 59%6 4%7 >90%7 n/a
Year 2011 2012 n/a n/a

 

Sources

1 United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2010 Revision. New York, 2011.

2 Durex Global Sex Survey Results 2005. Retrieved 20 June 2013, from http://www.durex.com/en-jp/sexualwellbeingsurvey/documents/gss2005result.pdf.

3 United Nations Economic Commission for Europe Statistical Division Database. Mean Age of Women at Birth of First Child by Country and Year. Updated 23 November 2012. Retrieved 19 June 2013, from http://w3.unece.org/pxweb/dialog/varval.asp?ma=04_GEFHAge1stChild_r&path=../database/STAT/30-GE/02-Families_households/&lang=1&ti=Mean+age+of+women+at+birth+of+first+child.

4 European health for all database (HFA-DB), World Health Organization Regional Office for Europe. Total fertility rate. Retrieved 18 June 2013, from http://data.euro.who.int/hfadb/.

5 United Nations Department of Economic and Social Affairs, Population Division. World Contraceptive Use 2012. New York, 2012.

6 Estimates based on local survey among women seeking induced abortion and women visiting youth clinics, 2011.

7 Personal communication, Kristina Gemzell Danielsson.

Last update: September 2015